30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United Kingdom

MGC Pharmaceuticals Limited

Track

Top insiders
Trades
Ana Arhar Oblak
Group Financial Controller
1 purchase — total 5,500 AUD
Buy 10 Jan 2024
Value A$1,372,618.71 | Price 17.65 | Shares 35,635
Buy 10 Jan 2024
Value A$2,164,466.79 | Price 491.18 | Shares 81,942
Buy 10 Jan 2024
Value A$605,000.00 | Price 0.55 | Shares 1,100,000
Buy 10 Jan 2024
Value A$165,000.00 | Price 0.55 | Shares 300,000
Buy 10 Jan 2024
Value A$9,350.00 | Price 0.55 | Shares 17,000
Buy 10 Jan 2024
Value A$330,000.00 | Price 0.55 | Shares 600,000
Buy 14 Jul 2023
Value £7,000.00 | Price 0.00 | Shares 5,833,333
Buy 14 Jul 2023
Value £2,600.00 | Price 0.00 | Shares 2,166,667
Buy 14 Jul 2023
Value £4,600.00 | Price 0.00 | Shares 3,833,333
Buy 14 Jul 2023
Value £5,300.00 | Price 0.00 | Shares 4,416,667
Sale 17 May 2023
Value A$3,500.00 | Price 0.01 | Shares 500,000
Sale 16 May 2023
Value A$6,136.45 | Price 0.01 | Shares 876,636
Buy 5 May 2023
Value A$77,137.50 | Price 0.01 | Shares 7,209,112
Buy 5 May 2023
Value A$9,380.01 | Price 0.01 | Shares 876,636
Buy 5 May 2023
Value A$75,735.01 | Price 0.01 | Shares 7,078,038
Buy 5 May 2023
Value A$121,550.00 | Price 0.01 | Shares 11,359,813
Buy 5 May 2023
Value A$68,572.90 | Price 0.01 | Shares 6,408,682
Buy 5 May 2023
Value A$80,653.10 | Price 0.01 | Shares 7,537,673
Buy 5 May 2023
Value A$74,332.50 | Price 0.01 | Shares 6,946,963
Sale 4 May 2023
Value A$4,000.00 | Price 0.01 | Shares 500,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-11 2024-01-10 B Purchase Ana Arhar Oblak

Group Financial Controller
35,635
17.65
A$1,372,619 		35,635 17.65 A$1,372,619
2024-01-11 2024-01-10 B Purchase Rowan Harland

Company Secretary
81,942
491.18
A$2,164,467 		81,942 491.18 A$2,164,467
2024-01-11 2024-01-10 B Purchase Yifat Steuer

Chief Operating Officer and Deputy CEO

Officer
22,446
394.52
A$4,682,335 		22,446 394.52 A$4,682,335
2024-01-11 2024-01-10 B Purchase Yair Tal

Chief Information Security Officer

Officer
300,000
0.55
A$165,000 		300,000 0.55 A$165,000
2024-01-11 2024-01-10 B Purchase Sabina Suljakovic

Vice President of Global Quality

Officer
17,000
0.55
A$9,350 		17,000 0.55 A$9,350
2024-01-11 2024-01-10 B Purchase Amir Polak

Chief Pharmaceutical Development Officer

Officer
600,000
0.55
A$330,000 		600,000 0.55 A$330,000
2023-07-18 2023-07-14 B Purchase Yifat Steuer

Chief Operating Officer and Deputy CEO

Officer
5,833,333
0.00
£7,000 		5,833,333 0.00 £7,000
2023-07-18 2023-07-14 B Purchase Yair Tal

Chief Information Security Officer

Officer
2,166,667
0.00
£2,600 		2,166,667 0.00 £2,600
2023-07-18 2023-07-14 B Purchase Itay Nissim

Chief Manufacturing and Supply Chain Officer

Officer
3,833,333
0.00
£4,600 		3,833,333 0.00 £4,600
2023-07-18 2023-07-14 B Purchase Amir Polak

Chief Pharmaceutical Development Officer

Officer
4,416,667
0.00
£5,300 		4,416,667 0.00 £5,300
2023-05-18 2023-05-17 S Sale Amir Polak

Chief Pharmaceutical Development Officer

Officer
500,000
0.01
A$3,500 		500,000 0.01 A$3,500
2023-05-18 2023-05-16 S Sale Nicole Godresse

Global Chief Sales Officer

Officer
876,636
0.01
A$6,136 		876,636 0.01 A$6,136
2023-05-10 2023-05-05 B Purchase Amir Polak

Chief Pharmaceutical Development Officer

Officer
7,209,112
0.01
A$77,138 		7,209,112 0.01 A$77,138
2023-05-10 2023-05-05 B Purchase Nicole Godress

Global Chief Sales Officer

Officer
876,636
0.01
A$9,380 		876,636 0.01 A$9,380
2023-05-10 2023-05-05 B Purchase Yair Tal

Chief Information Security Officer

Officer
7,078,038
0.01
A$75,735 		7,078,038 0.01 A$75,735
2023-05-10 2023-05-05 B Purchase Yifat Steuer

Chief Operating Officer and Deputy CEO

Officer
11,359,813
0.01
A$121,550 		11,359,813 0.01 A$121,550
2023-05-10 2023-05-05 B Purchase
Tom Cairns

Chief Accounting Officer

Officer
6,408,682
0.01
A$68,573 		6,408,682 0.01 A$68,573
2023-05-10 2023-05-05 B Purchase Robert Clements

Chief Commercial Officer

Officer
7,537,673
0.01
A$80,653 		7,537,673 0.01 A$80,653
2023-05-10 2023-05-05 B Purchase Itay Nissim

Chief Manufacturing and Supply Chain Officer

Officer
6,946,963
0.01
A$74,332 		6,946,963 0.01 A$74,332
2023-05-10 2023-05-04 S Sale Amir Polak

Chief Pharmaceutical Development Officer

Officer
500,000
0.01
A$4,000 		500,000 0.01 A$4,000
Explore more

More insider trading research around MGC Pharmaceuticals Limited

More insider trades in United Kingdom
Insider trading in Europe